Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
3.140
+0.050 (1.62%)
Aug 3, 2026, 4:00 PM EDT - Market closed
Evolent Health Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Evolent Health stock has a consensus rating of "Buy" and an average price target of $6.06. The average 1-year stock price forecast is 92.99% higher than the current stock price, while the lowest is $3.00 (-4.46%) and the highest is $8.00 (+154.78%).
Price Target: $6.06 (+92.99%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Evolent Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 10 | 8 | 6 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 15 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +59.24% | Jul 28, 2026 |
| Citi | Citi | Hold Reiterates $5.5 → $6.75 | Hold | Reiterates | $5.5 → $6.75 | +114.97% | Jul 23, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $6 → $7 | Buy | Maintains | $6 → $7 | +122.93% | Jul 21, 2026 |
| BTIG | BTIG | Buy Reiterates $8 | Buy | Reiterates | $8 | +154.78% | Jul 16, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $3 | Hold | Maintains | $3 | -4.46% | Jul 9, 2026 |
Financial Forecast
Revenue This Year
2.50B
from 1.88B
Increased by 33.35%
Revenue Next Year
2.93B
from 2.50B
Increased by 17.20%
EPS This Year
0.20
from 0.09
Increased by 117.36%
EPS Next Year
0.36
from 0.20
Increased by 84.10%
EPS and Forward PE are based on non-GAAP adjusted numbers.